Dr. Heym is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 Cooper St
Fort Worth, TX 76104Phone(682) 885-4007
Fax(682) 885-3914- Is this information wrong?
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2002 - 2005
New York Presbyterian HospitalResidency, Pediatrics, 1999 - 2002
Vanderbilt University School of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2006 - 2022
CA State Medical License 2005 - Present- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multi-center, Open Label, Non-controlled Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Pediatric Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP) or With Ph+ CML in CP or Accelerated Phase Start of enrollment: 2013 Aug 01Reddy, A.T.,Dome, J.S.,Chu, R.L.,Kerr, K.H.,Broxson, E.H.,Heym, K.M.,Bedros, A.A.,Brown, P.A.,Lee, A.,Ranalli, M.A.,Winick, N.J.,Marina, N.,Bertolone, S.J.,Levy, C.F.,Matloub, Y.H.,Lockhart, S.K.,Shen, V....
- A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL Start of enrollment: 2011 Dec 01Michael Burke, MD
- Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility Start of enrollment: 2009 Sep 01Mulligan, C.,Mullighan, C.,Schiff, D.,Heym, K.M.
- PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Terzah Horton, MD
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Sumit Gupta
- Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia Jeffrey E. Rubnitz, MD,PhD
Publications & Presentations
PubMed
- Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia.Seth E. Karol, Todd M. Cooper, Paul E. Mead, Kristine R. Crews, John C. Panetta, Thomas B. Alexander, Jeffrey W. Taub, Norman J. Lacayo, Kenneth Matthew Heym, Dennis J...> ;Cancer. 2020 Nov 1
- 2 citationsDecitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot StudyMichael J. Burke, Rumen Kostadinov, Richard Sposto, Lia Gore, Shannon Kelley, Cara A Rabik, Jane B. Trepel, Min-Jung Lee, Akira Yuno, Sunmin Lee, Deepa Bhojwani, Sima ...> ;Clinical Cancer Research. 2020 May 15
- Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.Franco Locatelli, James A. Whitlock, Christina Peters, Christiane Chen-Santel, Victoria M. Chia, Robyn M. Dennis, Kenneth Matthew Heym, Aaron J. Katz, Michael A. Kelsh...> ;Leukemia. 2020 Feb 24
- Join now to see all
Press Mentions
Hospital Patients March to Erase CancerAugust 31st, 2018
Hospital Affiliations
- Cook Children's Medical CenterFort Worth, Texas
Texas Health Harris Methodist Hospital Fort WorthFort Worth, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
